Abstract
To support the development of mRNA-based therapies, Thermo Fisher Scientific has developed a platform chromatography solution for the purification of mRNA. The POROS™ Oligo (dT)25 Affinity Resin helps to address the selectivity and capacity requirements for the large-scale manufacturing of mRNA used in vaccine and gene therapy applications. Typically, mRNA binds to the Oligo (dT)25 affinity resin using high ionic strength conditions and neutral pH and is eluted from the column using low ionic strength solutions such as water. Although water works well for most mRNA constructs, a need to identify alternative elution buffers to optimize mRNA recovery exists. This article describes experiments conducted to optimize mRNA purification using high-throughput screening.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
